BioNeex

Are you a development-stage biotech company and looking for licensing or co-development partners for your drug candidates? Then list them for FREE on @BioNeex_ and get contacted directly by your potential partners. #biopharma #biotech #pharma #biopharmaceutical

A peptide-peptide nucleic acid composed of a cell-penetrating peptide conjugated to a gene target-specific antisense peptide nucleic acid sequence for improved delivery into the bacterial cytoplasm. app.bioneex.com/drug-candidate…

A therapeutic candidate developed through a novel DNA-based drug delivery and development platform. Simplified method to deliver and use the patient’s own cells to manufacture the required proteins, T-cells, and antibodies in vivo for cancers. app.bioneex.com/drug-candidate…

A cell-penetrating peptide conjugated to a gene target-specific antisense peptide nucleic acid sequence for improved delivery into the bacterial cytoplasm. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #investors, #oncology, #Neurology, #hematology, #Immunology

A dual acting NLRP3 protein inhibitor that through its mechanism of action can reduce/preclude neurotoxicity in the CNS and PNS, specifically created by chemotherapy. app.bioneex.com/drug-candidate… #biotech, #investors, #oncology, #Neurology, #hematology, #Immunology

A TRPV1 receptor modulator with a proprietary formulation that contains purified synthetic cannabidiol with improved bioavailability and blood brain barrier transmission. app.bioneex.com/drug-candidate… #biotech, #investors, #oncology, #Neurology, #hematology, #Immunology

A drug candidate with no adverse effects, based on a platform, which not only reduces but also prevents high levels of LDL cholesterol. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #Science,#partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

A gene therapy to treat vision loss caused by RPGRIP1 mutations uses the novel Anc80 vector technology that has a superior delivery profile compared to commonly used AAVs. app.bioneex.com/drug-candidate… #biotech, #investors, #oncology, #Neurology, #hematology, #Immunology

A first-in-class allogeneic innate cell therapy with promising human data showing 80% tumour necrosis in end-stage carcinoma patients at low dose. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

A first-in-class antibiotic in the preclinical stage for drug-resistant Gram-negative pathogens, including N. gonorrhoeae and Pseudomonas aeruginosa. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

A non-antibiotic drug candidate for bacterial infections, which blocks the formation of disease-causing toxins without killing the pathogen and inhibits biofilm formation. app.bioneex.com/drug-candidate… #biotech, #investors, #oncology, #Neurology, #hematology, #Immunology

Cancer vaccine based on proprietary preparation of a protozoan, considered non-pathogenic to humans that overcomes the local cancer defenses of the Tumor Microenvironment. app.bioneex.com/drug-candidate… #biotech, #investors, #oncology, #Neurology, #hematology, #Immunology

A novel cancer vaccine based on proprietary preparation of modified protozoan that replicates in tumor cells and secretes anti-cancer cytokine, human Interleukin-15. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #Science, #oncology, #Neurology, #hematology, #Immunology

A modified non-pathogenic protozoan that restores immune competence in the tumor microenvironment and provokes potent anti-cancer immune response. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals,#partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

A glycooptimized recombinant follicle-stimulating hormone produced by proprietary platform. It combines safety of recombinant production and human glycosylation. app.bioneex.com/drug-candidate… #biotech, #Science,#partnerships, #investors,#oncology, #Neurology, #hematology, #Immunology

A drug candidate, consisting of a human cell expression system, which offers advantages over recombinant FVIIa forms like missing immunogenic glycan structures. app.bioneex.com/drug-candidate… #biotech, #partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

A novel drug candidate, designed to retain all Fv-mediated anti-tumor activities, largely improve anti-tumor efficacy via ADCC and reduce side effects. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

A novel drug candidate, designed to retain all Fv-mediated anti-tumor activities, largely improve anti-tumor efficacy via ADCC and reduce side effects. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

A glycooptimized anti-PD-L1 monoclonal antibody that combines strong inhibition of the PD1/PD-L1 interaction with improved T cell re-activation. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #Science,#partnerships, #investors, #oncology,#Neurology, #hematology,#Immunology